Communication Intervention for Cancer Care
(PRECursOr Trial)
Trial Summary
What is the purpose of this trial?
The purpose of this study is to help test an idea designed to foster more supportive talk between providers (doctors or nurse practitioners), patients, and caregivers during an outpatient oncology appointment. A caregiver is the person the patient identifies is primarily involved in their healthcare. This study is collecting your reaction to this idea in order to understand needed changes before we introduce the idea to a larger group of patients.
Do I have to stop taking my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications. It seems focused on communication during appointments, so it's unlikely that medication changes are required.
What data supports the idea that Communication Intervention for Cancer Care is an effective treatment?
The available research shows that effective communication in cancer care, such as the Communication Intervention for Cancer Care, improves patient understanding, satisfaction, and psychological adjustment. For example, one study highlights that meaningful communication helps patients better understand their disease and increases their satisfaction with care. Another study found that communication training for healthcare providers led to significant improvements in their confidence when talking to patients. These improvements suggest that the treatment is effective in enhancing the overall experience and outcomes for cancer patients.12345
What safety data exists for the Communication Intervention for Cancer Care?
The provided research does not directly address safety data for the Communication Intervention for Cancer Care or its variants. The studies focus on the efficacy and implementation of communication skills training in oncology, highlighting improvements in communication behaviors, patient comprehension, and clinician self-efficacy. However, they do not provide specific safety data or evaluations of potential risks associated with these interventions.14678
Is the treatment in the trial 'Communication Intervention for Cancer Care' a promising treatment?
Yes, the treatment is promising because effective communication in cancer care can improve patient understanding, satisfaction, and treatment outcomes. Training programs like COMSKIL show that communication skills can be taught and lead to better decision-making and emotional support for patients.1791011
Eligibility Criteria
This trial is for adult women with advanced, incurable gynecologic cancers who are at a critical point in their illness and have not responded well to initial treatments. They must speak English and not be receiving palliative care or hospice. Caregivers primarily involved in the patient's care can also participate if they meet similar language criteria.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Intervention group triads
Find a Clinic Near You
Who Is Running the Clinical Trial?
Indiana University
Lead Sponsor
American Cancer Society, Inc.
Collaborator